HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ADAMTS-1 contributes to the antifibrotic effect of captopril by accelerating the degradation of type I collagen in chronic viral myocarditis.

Abstract
Angiotensin-converting enzyme (ACE) inhibitors have been demonstrated to have antifibrotic activity in myocardial fibrosis. A distintegrin and metalloprotease with thrombospondin type 1 motifs (ADAMTS-1) is a newly discovered metalloproteinase. It was reported ADAMTS-1 had novel gelatin (type I collagen) degrading activities. We examined the role of ADAMTS-1 in the antifibrotic activity of the ACE inhibitor Captopril in a chronic viral myocarditis (CVMC) model. Balb/c mice were assigned to five groups: normal control group1 (group 1), normal control group2 (group 2), CVMC model group (group 3), CVMC control group (group 4) and Captopril therapy group (group 5). Group 3, 4 and 5 received Coxsackievirus B(3) to induce CVMC and group 5 was treated with Captopril (100mg/kg)for 28days. Heart sections were stained with picrosirius red and collagen volume fraction calculated. ADAMTS-1 expression was determined by Western blot. Type I collagen and carboxyterminal telopeptide of type I collagen (ICTP) were measured by RT-PCR. Group 4 mice had significantly increased collagen volume fraction compared to groups 2 and 5 (P<0.001, P<0.001, respectively) and higher type I collagen mRNA expression than groups 2 and 5 (P<0.001, P<0.001, respectively). Group 5 ADAMTS-1 and ICTP expression was significantly higher than in groups 2 and 4 (P<0.001, P<0.001, respectively). ADAMTS-1 levels in group 5 negatively correlated with collagen volume fraction (r=-0.68, P<0.01) and type I collagen (r=-0.67, P<0.01) but positively correlated with ICTP (r=0.72, P<0.01). We conclude that ADAMTS-1 contributes to the antifibrotic effect of Captopril by accelerating the degradation of type I collagen in CVMC.
AuthorsChunyan Guo, Yi Wang, Hao Liang, Jie Zhang
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 629 Issue 1-3 Pg. 104-10 (Mar 10 2010) ISSN: 1879-0712 [Electronic] Netherlands
PMID20006601 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2009 Elsevier B.V. All rights reserved.
Chemical References
  • Collagen Type I
  • Coloring Agents
  • Peptide Fragments
  • Peptides
  • Procollagen
  • collagen type I trimeric cross-linked peptide
  • Captopril
  • ADAM Proteins
  • ADAMTS1 Protein
  • Adamts1 protein, mouse
Topics
  • ADAM Proteins (metabolism)
  • ADAMTS1 Protein
  • Animals
  • Blotting, Western
  • Captopril (pharmacology, therapeutic use)
  • Chronic Disease
  • Collagen Type I (genetics, metabolism)
  • Coloring Agents (metabolism)
  • Fibrinolysis (drug effects)
  • Fibrosis (drug therapy)
  • Kinetics
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Myocarditis (drug therapy, metabolism, pathology, virology)
  • Peptide Fragments (genetics, metabolism)
  • Peptides
  • Procollagen (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Staining and Labeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: